Cargando…
Human resistin and the RELM of Inflammation in diabesity
The initial discovery of resistin and resistin-like molecules (RELMs) in rodents suggested a role for these adipocytokines in molecular linkage of obesity, Type 2 Diabetes mellitus and metabolic syndrome. Since then, it became apparent that the story of resistin and RELMs was very much of mice and m...
Autores principales: | Al Hannan, Fatima, Culligan, Kevin Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474570/ https://www.ncbi.nlm.nih.gov/pubmed/26097512 http://dx.doi.org/10.1186/s13098-015-0050-3 |
Ejemplares similares
-
Management of diabesity: Current concepts
por: Michaelidou, Maria, et al.
Publicado: (2023) -
Resistin-Like Molecule Beta (RELM-β) Regulates Proliferation of Human Diabetic Nephropathy Mesangial Cells via Mitogen-Activated Protein Kinases (MAPK) Signaling Pathway
por: Wang, Yun-Qian, et al.
Publicado: (2017) -
Retracted: Resistin-Like Molecule Beta (RELM-β) Regulates Proliferation of Human Diabetic Nephropathy Mesangial Cells via Mitogen-Activated Protein Kinases (MAPK) Signaling Pathway
por: Wang, Yun-Qian, et al.
Publicado: (2022) -
Diabesity management worldwide
por: Rajeswaran, Chinnadorai
Publicado: (2016) -
Linking resistin, inflammation, and cardiometabolic diseases
por: Park, Hyeong Kyu, et al.
Publicado: (2017)